Oric Pharmaceuticals, Inc. ORIC

13.16 (0.02) (0.15%) as of 25 Sep
Market cap
$1.4B
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Current Ratio 14.13 10.56 10.39 13.68 15.88 32.96 16.81 16.84 10.20
Net Debt/EBITDA 1.95 1.71 1.80 2.25 3.09 4.03 3.24 1.99 1.19
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE (41.27%) (54.73%) (45.11%) (35.99%) (27.98%) (73.82%) 34.80% 39.55% 40.78%
ROA (37.91%) (48.60%) (40.34%) (32.66%) (26.34%) (37.50%) (57.14%) 0.00% (57.40%)
ROIC (86.88%) 0.00% (435.43%) (356.70%) (136.94%) 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets (47.87%) (53.20%) (51.64%) (44.94%) (34.56%) (25.44%) (30.94%) (48.95%) (81.89%)
Free Cash Flow per Share (1.27) (1.63) (1.68) (1.95) (1.59) (2.09) (12.80) (12.23) (0.70)
Book value per Share 4.38 3.49 4.36 5.61 7.19 13.21 (47.44) 0.00 0.86
Free Cash Flow (111.68) (113.85) (86.54) (77.22) (60.48) (45.93) (24.30) (21.21) (20.83)
Other line items

Show all line items

Columns are period end dates